Press Releases

Press Releases

07.09.20
OpGen Subsidiary Curetis GmbH Secures Access to Additional EUR 5.0 Million Non-Dilutive Debt Financing Tranche from EIB
06.09.20
OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneumonia Identifies Life-Threatening Bacterial Co-Infections in COVID-19 Patients in Just Five Hours
06.03.20
OpGen Expands Partnership with New York State Department of Health and IDC to Detect Antimicrobial-Resistant Infections
05.11.20
OpGen CEO and Chairman of the Board Issue Letters to Stockholders
05.07.20
OpGen Reports First Quarter 2020 Financial Results and Provides Business Update
04.27.20
OpGen to Provide Business Update and Financial Results for the First Quarter 2020
04.21.20
OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study of Bacterial Co-Infections in COVID-19 Pneumonia Patients
04.16.20
OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing Based Antibiotic Susceptibility Testing in Multi-Center Study
04.14.20
OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update
04.01.20
OpGen and Curetis Successfully Close their Business Combination Transaction